Health Catalyst director granted 9.8K RSUs

Health Catalyst director Julie Larson-Green received a fully vested RSU equity award, increasing her direct holdings to 185,101 shares of common stock.

Rhea-AI Filing Summary

Health Catalyst, Inc. (symbol: HCAT) is the issuer of record for a Form 4 filing submitted to the SEC. Larson-Green Julie reported acquisition or exercise transactions in this Form 4 filing.

Health Catalyst, Inc. (HCAT) reported that director Julie Larson-Green received an award of 9,766 restricted stock units (RSUs) of common stock under the company’s 2019 Stock Option and Incentive Plan. Each RSU represents one share of common stock, and 100% of the RSUs vested on September 1, 2026, bringing her direct holdings to 185,101 shares. The award was granted at no cash purchase price, and no Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 9,766 shares

Grant/Award 1 txn

Insider Larson-Green Julie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	9,766	$0.00	$0.00

Holdings After Transaction: Common Stock — 185,101 shares (Direct)

Footnotes (1)

1. F1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on September 1, 2026.

Key Figures

RSUs granted: 9,766 RSUs Shares following transaction: 185,101 shares Transaction price per share: $0.00 per share +1 more

4 metrics

RSUs granted 9,766 RSUs Equity award to director Julie Larson-Green reported for September 1, 2026

Shares following transaction 185,101 shares Director’s direct holdings after RSU award

Transaction price per share $0.00 per share Award of RSUs granted without cash consideration

Vesting date September 1, 2026 100% of the 9,766 RSUs vested on this date

Key Terms

restricted stock units, 2019 Stock Option and Incentive Plan, Non-Employee Director Compensation Policy, Rule 10b5-1

4 terms

restricted stock units financial

"Represents an award of the Issuer's restricted stock units ("RSUs") granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan"

Non-Employee Director Compensation Policy financial

"in accordance with the terms of Issuer's Non-Employee Director Compensation Policy"

Rule 10b5-1 regulatory

"no Rule 10b5-1 plan is reported for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did HCAT disclose for Julie Larson-Green on this Form 4?

The filing reports that director Julie Larson-Green acquired 9,766 RSUs of Health Catalyst common stock as an equity award, which fully vested on September 1, 2026 and increased her direct holdings to 185,101 shares.

How many Health Catalyst (HCAT) shares does Julie Larson-Green own after this RSU grant?

After the reported RSU award, Julie Larson-Green directly owns 185,101 shares of Health Catalyst common stock, as stated in the Form 4’s post-transaction holdings field.

What are the key terms of the RSU award reported by HCAT for Julie Larson-Green?

The award consists of 9,766 RSUs granted under Health Catalyst’s 2019 Stock Option and Incentive Plan. Each RSU equals one share of common stock, and 100% vested on September 1, 2026, under the Non-Employee Director Compensation Policy.

Did Health Catalyst (HCAT) report any stock sales by Julie Larson-Green in this Form 4?

No. The Form 4 shows only an acquisition of 9,766 RSUs as a grant or award. There are no reported sales, dispositions, or derivative exercises in this filing.

Was the HCAT RSU transaction for Julie Larson-Green made under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is not checked, and the footnote does not reference any trading plan, so no Rule 10b5-1 plan is reported for this RSU award.

What plan governs the RSU grant to Julie Larson-Green reported by HCAT?

The RSU award was granted under Health Catalyst’s 2019 Stock Option and Incentive Plan and is described as being in accordance with the company’s Non-Employee Director Compensation Policy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:24 PM Accepted by SEC EDGAR 09/03/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larson-Green Julie

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		9,766(1)	A	$0.00	185,101	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on September 1, 2026.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)